On October 27, cleveland-cliffs rose 5.19% in Regular Trading, trading at $14.05 per share, with turnover of $32.5928 million.
The move coincided with continued market digestion of the company’s recent third-quarter results and subsequent analyst target price increases.
For the quarter reported on October 19, cleveland-cliffs posted adjusted EPS of $0.28, above consensus estimates of $0.19 to $0.21, while revenue rose to $5.612 billion from $4.73 billion a year earlier but came in slightly below expectations near $5.7 billion. The company also raised its 2027 adjusted EBITDA guidance. After that release, analysts lifted targets, including B. Riley to $18 from $15 while maintaining a Buy rating, and Morgan Stanley to $14 from $12.50 while keeping an Equalweight rating, supporting renewed attention on the earnings recovery story.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments